Overview.
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) combines a fasting glucose and fasting insulin measurement into a single number that estimates how resistant your cells are to insulin. It is one of the most widely used practical tools for identifying insulin resistance in clinical and research settings — detectable years before blood sugar becomes abnormal.
Context: Insulin resistance affects an estimated 30–40% of adults in developed countries, and most have no idea — because standard glucose tests often appear normal in the early stages. HOMA-IR can detect insulin resistance during the 'compensated' phase, when insulin is rising but glucose is still controlled. This window is the ideal time for lifestyle intervention.
Key takeaways.
- HOMA-IR requires two fasting blood tests: fasting insulin and fasting glucose
- Formula: (Fasting Insulin µIU/mL × Fasting Glucose mg/dL) ÷ 405
- If glucose is in mmol/L: (Fasting Insulin × Fasting Glucose) ÷ 22.5
- Scores below 1.0 indicate excellent insulin sensitivity
- Scores above 2.5 suggest insulin resistance in most adult populations
- HOMA-IR has limitations: it varies by ethnicity, age, and is not valid in type 1 diabetes or extreme hyperglycaemia
The Formula and What It Means.
HOMA-IR was developed by Matthews et al. in 1985 as a mathematical model of the fasting steady-state relationship between insulin and glucose. It is based on the physiological principle that in a healthy fasting state, insulin and glucose are held in a precise balance. When insulin rises to maintain a given glucose level, that indicates resistance — more hormonal effort is required to achieve the same metabolic effect. Two formula variants are in common use depending on the units used to report glucose:
- mg/dL formula (used in the US)
- HOMA-IR = (Fasting Insulin [µIU/mL] × Fasting Glucose [mg/dL]) ÷ 405
- mmol/L formula (used in the UK and Europe)
- HOMA-IR = (Fasting Insulin [µIU/mL] × Fasting Glucose [mmol/L]) ÷ 22.5
- Example calculation
- Fasting insulin 12 µIU/mL, fasting glucose 95 mg/dL: (12 × 95) ÷ 405 = 1,140 ÷ 405 = 2.81 — this is in the insulin resistance range
- Why 405 or 22.5?
- These divisors are empirically derived constants from the original model that normalise the product to a dimensionless score where 1.0 represents normal insulin sensitivity in the original study population
How to Get the Tests.
HOMA-IR is not itself a laboratory test — it is a calculation performed on the results of two standard blood tests that must be drawn together in a fasted state.
- Fasting insulin
- Often not included in routine panels. You may need to specifically request it. Many GPs and primary care providers will order it if asked.
- Fasting glucose
- Standard and widely available — it is part of most basic metabolic panels (BMP/CMP). Make sure both tests come from the same blood draw.
- Fasting requirements
- 10–12 hours of fasting (water is fine). Both tests must be fasting — non-fasting insulin is not useful for HOMA-IR.
- Can I use home glucose tests?
- No. Home glucometers have insufficient precision for HOMA-IR calculation. Both tests must come from a laboratory blood draw.
Interpreting Your Score.
HOMA-IR thresholds vary in the medical literature depending on the population studied. The values below represent commonly used reference points from published validation studies, but your doctor may apply different thresholds based on your clinical context, ethnicity, and local guidelines.
- Below 1.0
- Excellent insulin sensitivity. Reflects efficient glucose metabolism.
- 1.0 to 1.9
- Normal range for most adults. Some variation by age, ethnicity, and body composition is expected.
- 2.0 to 2.9
- Borderline. This range warrants lifestyle attention — reduce refined carbohydrates, increase physical activity, and retest in 3–6 months. Some guidelines define insulin resistance beginning here.
- 3.0 and above
- Insulin resistance is likely. In a Spanish population study, a cut-off of approximately 2.5–3.0 defined insulin resistance with reasonable sensitivity and specificity for identifying metabolic syndrome in adults. Clinical follow-up is appropriate.
- Above 4.0 to 5.0
- Significant insulin resistance indicating metabolic dysfunction. Associated with elevated risk of type 2 diabetes, MASLD (fatty liver), and cardiovascular disease.
Important Limitations.
HOMA-IR is a useful screening tool but not a diagnostic gold standard. Understanding its limitations prevents over- or under-interpretation.
- Ethnicity matters
- Optimal cut-off values vary by ethnicity. South Asian populations tend to have higher HOMA-IR at lower BMI. East Asian populations may show insulin resistance at lower scores than European populations. Thresholds validated in one population may not directly transfer to another.
- Not valid in type 1 diabetes
- HOMA-IR is meaningless in type 1 diabetes because these individuals have impaired insulin secretion. The formula assumes intact beta-cell function.
- High glucose invalidates the model
- In frank diabetes (glucose > 200 mg/dL or 11 mmol/L), HOMA-IR becomes less reliable. It performs best in the pre-diabetic and early insulin resistance range.
- Fasting insulin assay variability
- Different laboratory immunoassays report fasting insulin with considerable inter-lab variation (up to 20–30%). Results should be interpreted using the same lab over time for tracking progress.
- Single-point measurement
- HOMA-IR is a snapshot. Fasting insulin can vary day-to-day. For clinical decisions, trends over 3–6 months are more meaningful than a single measurement.
- Does not replace gold-standard testing
- The euglycaemic-hyperinsulinaemic clamp is the research gold standard for measuring insulin resistance. HOMA-IR correlates well with the clamp in populations without extreme hyperglycaemia, but clinical correlation is still needed.
Improving Your HOMA-IR Score.
Insulin resistance is highly modifiable. Meaningful improvements in HOMA-IR are achievable within 8–12 weeks of targeted lifestyle change.
- Resistance training
- Building skeletal muscle mass is the single most effective long-term intervention — muscle is the primary site of insulin-stimulated glucose uptake. Aim for 2–3 sessions per week.
- Aerobic exercise
- Zone 2 cardio (conversational pace) for 150+ minutes per week improves mitochondrial function and acute insulin sensitivity. The effect is measurable within days of a single bout of exercise.
- Dietary carbohydrate quality
- Reducing refined carbohydrates (sugar, white flour, ultra-processed foods) while maintaining adequate fibre and protein tends to lower both fasting insulin and glucose. This is the most direct dietary lever on HOMA-IR.
- Sleep quality
- A single night of poor sleep (< 6 hours) can measurably worsen insulin sensitivity the next day. Chronic sleep restriction drives insulin resistance independent of diet.
- Weight loss
- Even a 5–10% reduction in body weight — especially loss of visceral (abdominal) fat — produces meaningful HOMA-IR improvement. Fat distribution matters more than total weight.
FAQs.
Can I have insulin resistance with a normal HOMA-IR?
Yes, in certain circumstances. HOMA-IR reflects fasting insulin secretion and glucose, but insulin resistance can be more pronounced post-meal (post-prandial) than at fasting. Some people with clear metabolic syndrome or post-meal glucose spikes will have a borderline HOMA-IR. In these cases, a 2-hour oral glucose tolerance test (OGTT) with insulin measurement provides additional information.
How often should I retest HOMA-IR?
If you are making lifestyle changes to address insulin resistance, retesting every 3–6 months allows you to track progress. For annual health monitoring in people without known metabolic dysfunction, yearly testing alongside a standard metabolic panel is reasonable.
My glucose is completely normal but my HOMA-IR is 3.2. How is that possible?
This is the key insight behind HOMA-IR. Your pancreas is compensating for insulin resistance by producing elevated insulin — which keeps your glucose looking normal. But the elevated fasting insulin is doing extra work to maintain that normal glucose, and HOMA-IR captures this relationship. This is early, compensated insulin resistance — the ideal time to intervene before glucose eventually rises.
My doctor says my glucose and HbA1c are fine. Why should I test insulin at all?
Standard glucose tests can remain normal for 10–20 years while insulin resistance is silently progressing. HbA1c only becomes abnormal once the pancreas can no longer fully compensate. Testing fasting insulin and calculating HOMA-IR provides early visibility into metabolic health that glucose tests alone cannot offer. It is especially valuable if you have any features of metabolic syndrome: abdominal obesity, elevated triglycerides, low HDL, or hypertension.